Cargando…

Perspectives on the Evolution of Stem Cell Therapy for Heart Failure

Detalles Bibliográficos
Autores principales:	Tompkins, Bryon, Balkan, Wayne, Hare, Joshua M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703738/ https://www.ncbi.nlm.nih.gov/pubmed/26844249 http://dx.doi.org/10.1016/j.ebiom.2015.11.043

Ejemplares similares

Mesenchymal Stem Cell Therapy for Aging Frailty
por: Schulman, Ivonne Hernandez, et al.
Publicado: (2018)

Clinical-based Cell Therapies for Heart Disease—Current and Future State
por: Turner, Darren, et al.
Publicado: (2020)

Allogeneic Cell Combination Therapy Ameliorates Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction
por: Rieger, Angela C, et al.
Publicado: (2022)

Can't Patch Everything: Personalized Medicine for Cell Therapy in Dilated Cardiomyopathy
por: Sundin, Andrew, et al.
Publicado: (2021)

Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells
por: Premer, Courtney, et al.
Publicado: (2015)

Pharmacists’ Role in the Care of Patients with Heart Failure: Review and Future Evolution
por: Cheng, Judy W.M., et al.
Publicado: (2014)

Did giraffe cardiovascular evolution solve the problem of heart failure with preserved ejection fraction?
por: Natterson-Horowitz, Barbara, et al.
Publicado: (2021)

Successful glucose lowering therapy triumphs in heart failure
por: Rossing, Peter
Publicado: (2021)

Perspective on the New American Heart Association/American College of Cardiology Guidelines for the Management of Adults with Congenital Heart Disease
por: Van Hare, George F.
Publicado: (2018)

The Evolution of the Stem Cell Theory for Heart Failure
por: Silvestre, Jean-Sébastien, et al.
Publicado: (2015)

S-nitrosylation and MSC-mediated body composition
por: Cao, Yenong, et al.
Publicado: (2015)

The real-life heart failure patient: importance of guideline-directed medical therapy
por: van Hout, G. P. J., et al.
Publicado: (2021)

Stem Cells: A Personal Perspective
por: Wong, SC
Publicado: (2011)

Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction
por: Johnston, Peter V., et al.
Publicado: (2019)

Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction?
por: Kaur, Navjyot, et al.
Publicado: (2021)

Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure
por: Malgie, Jishnu, et al.
Publicado: (2023)

Failure of the stem cell niche rather than loss of oocyte stem cells in the aging ovary
por: Massasa, Efi, et al.
Publicado: (2010)

Biosecurity Concept: Origins, Evolution and Perspectives
por: Renault, Véronique, et al.
Publicado: (2021)

Commentary: Mending a broken heart: The ongoing quest for mesenchymal stem cell therapy for ischemic cardiomyopathy
por: Spinetti, Gaia, et al.
Publicado: (2021)

Improve self-care in heart failure
por: Jiang, Ying, et al.
Publicado: (2021)

Focus on HFpEF in heart failure
por: He, Chunhui, et al.
Publicado: (2022)

New perspectives in human stem cell therapeutic research
por: Trounson, Alan
Publicado: (2009)

advancements in stem cell research : an Indian perspective-ll
por: Rajarathna,
Publicado: (2010)

Cognitive impairment and depression in heart failure: ‘cardiological giants’
por: Pons, D., et al.
Publicado: (2021)

Preserving mitochondria to treat hypertrophic cardiomyopathy: From rare mitochondrial DNA mutation to heart failure therapy?
por: Diwan, Abhinav
Publicado: (2023)

Hybrid approach of ventricular assist device and autologous bone marrow stem cells implantation in end-stage ischemic heart failure enhances myocardial reperfusion
por: Anastasiadis, Kyriakos, et al.
Publicado: (2011)

CardioMEMS: the next revolution in heart failure management?
por: Handoko, M. L., et al.
Publicado: (2019)

Combination stem cell therapy for heart failure
por: Ichim, Thomas E, et al.
Publicado: (2010)

Stem cell therapy for congestive heart failure
por: Gunduz, E, et al.
Publicado: (2011)

Glucosamine regulates macrophage function in heart failure
por: Wysoczynski, Marcin, et al.
Publicado: (2022)

Coagulation factor with potential for the treatment of heart failure
por: Cao, Yang, et al.
Publicado: (2022)

Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure
por: Taylor, Doris A
Publicado: (2001)

The Nexus of Atrial Fibrillation, Heart Failure, and Cardiac Pacing Therapies in 2022
por: Niazi, Imran
Publicado: (2023)

Mesenchymal Stem Cell Secretion of SDF-1α Modulates Endothelial Function in Dilated Cardiomyopathy
por: Premer, Courtney, et al.
Publicado: (2019)

A brief perspective on neural cell therapy
por: Pruszak, Jan
Publicado: (2014)

Debate: Should statin be used in patients with heart failure?
por: Pietro Maggioni, Aldo
Publicado: (2001)

Debate: Statins should be used in patients with heart failure
por: Kjekshus, John
Publicado: (2001)

Prediabetes and risk of heart failure: the link grows stronger
por: Wu, Jian-di, et al.
Publicado: (2021)

Commentary: Stimulating new options for heart failure management
por: Ryan, Christopher T., et al.
Publicado: (2022)

Behind the developing brains and beating hearts of stem cell-derived embryo models
por: Amadei, Gianluca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aa3mlolif53rqvujr27vic4300